Thursday, June 21, 2012

Two days after a Canadian Private Equity firm buys Orpharma, registered users get email on how to increase sales to fix your gum “pockets”

Valeant buys Orapharma for $312 million. 

I have been told there is no real scientific evidence to any of this Arestin stuff. And if I remember right the American Heart Association came out earlier this year and announced there was no real evidence associated with heart disease as you may be told.

I don’t have a clue either way. What I know is a Private Equity firm out of Canada is suggesting high pressure sales tactics the public should be made aware of.Just like the public needs to be aware of the drug companies and their sales techniques - which are many times very dangerous – the public needs to know this.arestinadafterpurchase

Here is just one of Arestin's sales training videos.